369 related articles for article (PubMed ID: 29432935)
1. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Tscharre M; Herman R; Rohla M; Hauser C; Farhan S; Freynhofer MK; Huber K; Weiss TW
Atherosclerosis; 2018 Mar; 270():173-179. PubMed ID: 29432935
[TBL] [Abstract][Full Text] [Related]
2. Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
Lim SS; Yang YL; Chen SC; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Chou CY; Pan JP; Charng MJ; Chen YH; Wu TC; Lu TM; Hsu PF; Huang PH; Cheng HM; Huang CC; Sung SH; Lin YJ; Leu HB
Atherosclerosis; 2020 Mar; 297():40-46. PubMed ID: 32062138
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia as a prognostic factor after acute coronary syndrome.
Lopez-Pineda A; Cordero A; Carratala-Munuera C; Orozco-Beltran D; Quesada JA; Bertomeu-Gonzalez V; Gil-Guillen VF; Bertomeu-Martinez V
Atherosclerosis; 2018 Feb; 269():229-235. PubMed ID: 29407598
[TBL] [Abstract][Full Text] [Related]
4. Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.
Joo HJ; Jeong HS; Kook H; Lee SH; Park JH; Hong SJ; Yu CW; Lim DS
BMC Cardiovasc Disord; 2018 Jun; 18(1):114. PubMed ID: 29890945
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
Kawabe M; Sato A; Hoshi T; Sakai S; Hiraya D; Watabe H; Kakefuda Y; Ishibashi M; Abe D; Takeyasu N; Aonuma K
J Cardiol; 2016 Feb; 67(2):170-6. PubMed ID: 26228000
[TBL] [Abstract][Full Text] [Related]
6. Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension.
Perticone M; Tripepi G; Maio R; Cimellaro A; Addesi D; Baggetta R; Sciacqua A; Sesti G; Perticone F
Int J Cardiol; 2017 Sep; 243():473-478. PubMed ID: 28528984
[TBL] [Abstract][Full Text] [Related]
7. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of inflammation and malnutrition for long-term prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study.
Yuxiu Y; Ma X; Gao F; Liu T; Deng J; Wang Z
BMC Cardiovasc Disord; 2024 Jun; 24(1):306. PubMed ID: 38886675
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
10. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
[TBL] [Abstract][Full Text] [Related]
11. A high level of uric acid is associated with long-term adverse cardiovascular outcomes in patients who received fractional flow reserve with coronary intermediate stenosis.
Li F; Lin Q; Zhou J; Zhu J; Zhou Y; Wu K; Li Q; Zhao D; Liu Q
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1538-1545. PubMed ID: 38644080
[TBL] [Abstract][Full Text] [Related]
12. Impacts of geriatric nutritional risk index on prognosis of patients with non-ST-segment elevation acute coronary syndrome: Results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1685-1696. PubMed ID: 32641219
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Liu C; Zhao Q; Ma X; Cheng Y; Sun Y; Zhang D; Liu X; Zhou Y
Cardiovasc Diabetol; 2022 Jan; 21(1):11. PubMed ID: 35045846
[TBL] [Abstract][Full Text] [Related]
15. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
16. Impact of hyperuricemia on coronary blood flow and in-hospital mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Nakahashi T; Sakata K; Masuda J; Kumagai N; Higuma T; Ogimoto A; Tanigawa T; Hanada H; Nakamura M; Takamura M; Dohi K
J Cardiol; 2022 Sep; 80(3):268-274. PubMed ID: 35589464
[TBL] [Abstract][Full Text] [Related]
17. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
18. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
[TBL] [Abstract][Full Text] [Related]
19. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Zhang J; He L
BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772
[TBL] [Abstract][Full Text] [Related]
20. Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention.
Tscharre M; Farhan S; Bruno V; Rohla M; Egger F; Weiss TW; Hübl W; Willheim M; Wojta J; Geppert A; Huber K; Freynhofer MK
Eur J Clin Invest; 2019 Sep; 49(9):e13157. PubMed ID: 31318979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
